NCT03207594

Brief Summary

The purpose of this study is to improve cancer care and the delivery of cancer care. Researchers are interested in studying patient reported information and examining how different factors may impact cancer care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
128

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

March 22, 2017

Completed
4 months until next milestone

First Posted

Study publicly available on registry

July 5, 2017

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
Last Updated

January 31, 2025

Status Verified

January 1, 2025

Enrollment Period

2.7 years

First QC Date

March 22, 2017

Last Update Submit

January 29, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of patients with biochemically confirmed smoking cessation

    Biochemical confirmation will be determined by saliva samples

    4 weeks after enrollment

  • Number of patient who self-report smoking cessation

    Self-reported smoking cessation will be documented via smoking assessment questionnaire

    4 weeks after enrollment

Secondary Outcomes (3)

  • Average weekly smoke exposure

    up to 62 weeks

  • Number of patients who participate in smoking cessation

    up to 12 months after completion of RT.

  • Compliance with smoking cessation

    up to 12 weeks after completion of RT

Study Arms (1)

Arm 1

Current smokers with cancer who are planning to get radiation therapy at MUSC.

Other: SurveyOther: Saliva sampleOther: Smoking Status questions

Interventions

SurveyOTHER

Subjects will be asked to complete a survey asking questions about his/her current health, well-being and quality of life.

Arm 1

Subjects will have saliva collected by a member of the study team using a cotton swab.

Arm 1

Subjects will be asked to complete an assessment asking questions about his/her current smoking status

Arm 1

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient who have been diagnosed with head/neck, lung, breast, prostate, gastrointestinal or gynecologic cancers that are 21 years of age or older. Patients must have been referred to MUSC radiation oncology for treatment with curative radiation therapy

You may qualify if:

  • Diagnosed with head/neck, lung, breast, prostate, gastrointestinal or gynecologic cancer
  • years of age or older at time of study registration
  • Must have been referred to MUSC radiation oncology for treatment with curative radiation therapy
  • Must report current smoking defined as self-reporting smoking within the past 30 days using a structured intake questionnaire.

You may not qualify if:

  • Patients with primary central nervous system malignancies will be excluded.
  • Patients that have other cancer disease types will be excluded due to either significant differences in standard radiation therapy approaches or rarity of disease required radiation.
  • Patients who are currently participating in the Medical University of South Carolina Hollings Cancer Center smoking cessation program
  • Patients who are unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

MeSH Terms

Conditions

Head and Neck NeoplasmsProstatic NeoplasmsBreast NeoplasmsLung NeoplasmsGastrointestinal Neoplasms

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsGenital Neoplasms, MaleUrogenital NeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesDigestive System NeoplasmsDigestive System DiseasesGastrointestinal Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Graham Warren, MD, PhD

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2017

First Posted

July 5, 2017

Study Start

September 1, 2016

Primary Completion

May 1, 2019

Study Completion

March 1, 2020

Last Updated

January 31, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations